Compare NECB & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NECB | PROF |
|---|---|---|
| Founded | 1934 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.9M | 270.7M |
| IPO Year | 2021 | 2017 |
| Metric | NECB | PROF |
|---|---|---|
| Price | $23.73 | $5.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 29.5K | ★ 277.7K |
| Earning Date | 04-20-2026 | 03-05-2026 |
| Dividend Yield | ★ 4.19% | N/A |
| EPS Growth | N/A | ★ 25.89 |
| EPS | ★ 3.25 | 1.41 |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | $9.76 | $115.41 |
| Revenue Next Year | $11.94 | $60.63 |
| P/E Ratio | $7.36 | ★ $3.67 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $19.27 | $3.90 |
| 52 Week High | $25.18 | $8.95 |
| Indicator | NECB | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 44.56 |
| Support Level | $22.25 | $5.38 |
| Resistance Level | $24.50 | $5.98 |
| Average True Range (ATR) | 0.62 | 0.51 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 64.42 | 42.86 |
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.